Delivery Order SPE2DB20D2014-SPE2DB23FC81Q
Award Date 7/21/23
Potential Completion Date 7/24/23
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $689 to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 15, 2023 through June 16, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military readiness by...
- The Defense Logistics Agency awarded a $1,308 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 25, 2023 through August 28, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle and will provide needed pharmaceutical products to support DOD missions. No...
- The Defense Logistics Agency awarded a $689 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 8-9, 2023. This delivery order was issued against an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. No set aside designation...
- The Defense Logistics Agency awarded a $34,316.57 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance will be Conshohocken, Pennsylvania over the period of September 11-12, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, stocking over five million items for America's armed forces and partner nations. This delivery...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,783 to Amerisourcebergen Drug Corporation for the supply of 120 capsules of 1 gram Icosapent Ethyl. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15 through September 18, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for a cardiovascular drug is consistent with...
- The Defense Logistics Agency awarded a $890 delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 3 through July 5, 2023. No additional details were provided regarding the larger vehicle or programs supported through this pharmaceutical procurement. The prime contractor will deliver the requested...
- The Defense Logistics Agency awarded a $1,269.49 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning just one day from June 20, 2023 to June 21, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency functions to...
- The Defense Logistics Agency awarded a $783.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 8, 2023 under the terms of the contract. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports United States military services...
- The Defense Logistics Agency awarded a delivery order valued at $452,250 to Amerisourcebergen Drug Corporation for the provision of 120 capsules of 1 gram Icosapent Ethyl capsules. This firm fixed price order is being carried out under the Prime Vendor Program, with performance taking place in Conshohocken, Pennsylvania from August 18-21, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply chain for the United States...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $2,317.34 to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is limited to July 12 through July 13, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FC81QDelivery Order
The Defense Logistics Agency awarded a $3,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of 1 gram Icosapent Ethyl capsules. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 21, 2023 through July 24, 2023. As the DLA supports the logistical needs of the Department of Defense, this delivery order was likely placed to supply a military treatment facility with this pharmaceutical to manage certain cardiovascular risks for eligible beneficiaries. No major subcontractors or set aside designations were indicated in the award information.
Generated 12/15/23, 10:41 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 7/21/23 |